🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, randomized, 3 treatment, 3-period, 6-sequence, cross...
Status
Completed
Location
Celerion
Start Date
2018-05-24
Trial ID
NCT03540836
This is a Phase 3, double-blind, placebo-controlled, randomized-withdrawal ...
Status
Completed
Location
Site 21
Start Date
2018-11-15
Trial ID
NCT03697109
Treatments Being Tested
A study designed to characterize the plasma pharmacokinetic (PK) profile of...
Status
Completed
Location
Quotient Sciences, Miami, Inc.
Start Date
2017-05-18
Trial ID
NCT06094790
Treatments Being Tested
The study is an open-label Phase 1 study of the combination of relacorilant...
Status
Completed
Location
University Of Chicago Medicine Comprehensive Cancer Center
Start Date
2018-10-23
Trial ID
NCT03674814
Treatments Being Tested
This study will investigate the safety and efficacy of Relacorilant in comb...
Status
Completed
Location
Site #150, Stanford Cancer Center
Start Date
2020-09-30
Trial ID
NCT04373265
Treatments Being Tested
The primary objective of this multiple-dose, adaptive design study is to ev...
Status
Completed
Location
Clinical Pharmacology of Miami, LLC
Start Date
2020-01-06
Trial ID
NCT06094725
Treatments Being Tested
This is an open-label extension study to evaluate the long-term safety of r...
Status
Active Not Recruiting
Location
Site 49
Start Date
2018-05-07
Trial ID
NCT03604198
Treatments Being Tested
This is a 2-part, Phase 2 study to evaluate the safety, tolerability, dosin...
Status
Recruiting
Location
Site 02
Start Date
2026-01-27
Trial ID
NCT07259317
Treatments Being Tested
This is a Phase 3, open-label study to evaluate the objective response rate...
Status
Terminated
Location
Site #038
Start Date
2020-06-30
Trial ID
NCT04329949
Treatments Being Tested
The primary objective of the study is to evaluate the effects of a high-fat...
Status
Completed
Location
inVentiv Health Clinical Research Services LLC
Start Date
2020-09-19
Trial ID
NCT06094738